Beranda › Karsinoma Urotelial (Sel Transisional) › California › Irvine
Uji klinis Karsinoma Urotelial (Sel Transisional) di Irvine, CA
8 studi untuk Karsinoma Urotelial (Sel Transisional) mencari peserta di lokasi sekitar Irvine (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Menerima pesertaFase 3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Menerima pesertaFase 1
- City of Hope at Irvine Lennar, Irvine
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Menerima pesertaFase 1/2
- UCLA Hematology/Oncology - Irvine, Irvine
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine Infusion Pharmacy ACC, Irvine
- dan 2 lainnya
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Menerima pesertaFase 3
- Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Menerima pesertaFase 1
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Menerima pesertaFase 2
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- Kaiser Permanente Alton/Sand Canyon Medical Offices, Irvine
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Menerima pesertaFase 1
- COH Lennar, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Irvine
Uji klinis Karsinoma Urotelial (Sel Transisional) di kota lain
- Nashville, TN23 studi
- New York City, NY22 studi
- Houston, TX19 studi
- Dallas, TX18 studi
- Edison, NJ18 studi
- Los Angeles, CA17 studi
- Queens, NY15 studi
- Chicago, IL14 studi
- Arlington, VA12 studi
- Boston, MA11 studi
- San Antonio, TX11 studi
- Austin, TX10 studi
Studi lain di Irvine
- Kanker Paru Non-Sel Kecil25 studi
- Kanker Payudara23 studi
- Kanker (semua jenis)17 studi
- Kanker Metastatik16 studi
- Kanker Paru15 studi
- Mieloma Multipel14 studi
- Kanker Prostat14 studi
- Kanker Ovarium12 studi
- Karsinoma Sel Skuamosa Kepala dan Leher11 studi
- Kanker Kandung Kemih11 studi
- Penyakit Alzheimer11 studi
- Kanker Kolorektal10 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.